Ovarian Cancer Therapy
Reports summarize ovarian cancer therapy research from University of South Dakota
Published in Women's Health Weekly, August 23rd, 2007
Fresh data on ovarian cancer are presented in the report "Combined staining of TAG-72, MUC1, and CA125 improves labeling sensitivity in ovarian cancer: antigens for multi-targeted antibody-guided therapy." According to a study from the United States, "Single antigen-targeted intraperitoneal radioimmunotherapy for ovarian cancer has shown limited success. Due to the heterogeneous expression of tumor antigens on cancer cells, a multi-antigen targeting approach appears logical to augment the therapeutic efficacy of antibody-guided therapy."
"In the interest of developing this novel approach, ovarian cancer tissue microarray slides containing cancer and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Baylor Regional Medical Center
Food Isn’t the Only Thing That Can Expire—Old Makeup Can Harbor Dangerous Bacteria - Bioengineering
Seeking Markers for Menopausal Women at Risk for a Deadly Blood Clot - Breast Implants
Breast Implants Linked to Higher Suicide Risk - Cancer Vaccines
Simple screening technique for cervical cancer can reduce incidence in poor countries - Dartmouth Medical School
Postpartum hospital discharges -- when is the 'right time?' - Depression
Why Women Get More Migraines Than Men - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
